Advertisement

Arrhythmias in myocarditis: State of the art

Published:November 23, 2018DOI:https://doi.org/10.1016/j.hrthm.2018.11.024
      Many kinds of arrhythmias may occur in patients with myocarditis at any stage of the disease. However, compared to the other clinical presentations, arrhythmic myocarditis has been poorly described in the literature. Arrhythmias occurring in either ongoing or previous myocardial inflammation are complex and heterogeneous, and the disease itself is often underdiagnosed, thus limiting data collection and interpretation. However, different from the other clinical presentations, arrhythmic myocarditis requires specific diagnostic, prognostic, and therapeutic considerations. The aim of this review is to critically summarize the state of the art on myocarditis presenting with arrhythmias in terms of epidemiology, etiology, diagnosis, prognosis, and treatment.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Heart Rhythm
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Cooper Jr., L.T.
        Myocarditis.
        N Engl J Med. 2009; 360: 1526-1538
        • Baksi A.J.
        • Kanaganayagam G.S.
        • Prasad S.K.
        Arrhythmias in viral myocarditis and pericarditis.
        Card Electrophysiol Clin. 2015; 7: 269-281
        • Caforio A.L.P.
        • Pankuweit S.
        • Arbustini E.
        • et al.
        Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Disease.
        Eur Heart J. 2013; 34: 2636-2648
        • Priori S.G.
        • Blomström-Lundqvist C.
        • Mazzanti A.
        • et al.
        2015 European Society of Cardiology (ESC) guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death.
        Europace. 2015; 17: 1601-1687
        • Corrado D.
        • Basso C.
        • Thiene G.
        Sudden cardiac death in young people with apparently normal heart.
        Cardiovasc Res. 2001; 50: 399-408
        • Maron B.J.
        • Udelson J.E.
        • Bonow R.O.
        • et al.
        Eligibility and disqualification recommendations for competitive ethletes with cardiovascular abnormalities—a scientific statement from the American Heart Association and American College of Cardiology.
        Circulation. 2016; 132: e273-e280
        • Cooper Jr., L.T.
        • Berry G.J.
        • Shabetai R.
        • for the Multicenter Giant Cell Myocarditis Study Group Investigators
        Idiopathic giant-cell myocarditis: natural history and treatment.
        N Engl J Med. 1997; 336: 1860-1866
        • Birnie D.H.
        • Sauer W.H.
        • Bogun F.
        • et al.
        HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis.
        Heart Rhythm. 2014; 11: 1305-1323
        • Imazio M.
        • Trinchero R.
        Myopericarditis: etiology, management, and prognosis.
        Int J Cardiol. 2008; 127: 17-26
        • Larsen B.T.
        • Maleszewski J.J.
        • Edwards W.D.
        • Cooper Jr., L.T.
        • Sobonya R.E.
        • Thompson V.E.
        • Duckett S.G.
        • Peebles C.R.
        • Simpson I.A.
        • Tazelaar H.D.
        Atrial giant cell myocarditis: a distinctive clinicopathologic entity.
        Circulation. 2013; 127: 39-47
        • Ammirati E.
        • Cipriani M.
        • Moro C.
        • et al.
        Clinical presentation and outcome in a contemporary cohort of patients with acute myocarditis: the Multicenter Lombardy Registry.
        Circulation. 2018; 15 (e118.035319)
        • Caforio A.L.P.
        • Adler Y.
        • Agostini C.
        • et al.
        Diagnosis and management of myocardial involvement in systemic immune-mediated diseases: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Disease.
        Eur Heart J. 2017; 38: 2649-2662
        • Okura Y.
        • Dec G.W.
        • Hare J.M.
        • Kodama M.
        • Berry G.J.
        • Tazelaar H.D.
        • Bailey K.R.
        • Cooper L.T.
        A clinical and histopathologic comparison of cardiac sarcoidosis and idiopathic giant cell myocarditis.
        J Am Coll Cardiol. 2003; 41: 322-328
        • Andreoletti L.
        • Leveque N.
        • Boulagnon C.
        • Brasselet C.
        • Fornes P.
        Viral causes of human myocarditis.
        Arch Cardiovasc Dis. 2009; 102: 559-568
        • Milei J.
        • Grana D.
        • Fernandez Alonso G.
        • Matturri L.
        Cardiac involvement in acquired immunodeficiency syndrome—a review to push action. The Committee for the Study of Cardiac Involvement in AIDS.
        Clin Cardiol. 1998; 21: 465-472
        • Wesslen L.
        • Pahlson C.
        • Lindquist O.
        • et al.
        An increase in sudden unexpected cardiac deaths among young Swedish orienteers during 1979–1992.
        Eur Heart J. 1996; 17: 902-910
        • Durrance R.J.
        • Ullah T.
        • Atif Z.
        • Frumkin W.
        • Doshi K.
        Chagas cardiomyopathy presenting as symptomatic bradycardia: an underappreciated emerging public health problem in the United States.
        Case Rep Cardiol. 2017; : 572-574
        • Al-Khatib S.M.
        • Stevenson W.G.
        • Ackerman M.J.
        • et al.
        2017 AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death.
        Heart Rhythm. 2017; : S1547-S5271
        • Bozkurt B.
        • Colvin M.
        • Cook J.
        • et al.
        Current diagnostic and treatment strategies for specific dilated cardiomyopathies: a scientific statement from the American Heart Association.
        Circulation. 2016; 134: e579-e646
        • Caforio A.L.P.
        • Malipiero G.
        • Marcolongo R.
        • Iliceto S.
        Myocarditis: a clinical overview.
        Curr Cardiol Rep. 2017; 19: 63
        • Friedrich M.G.
        • Sechtem U.
        • Schulz-Menger J.
        • et al.
        Cardiovascular magnetic resonance in myocarditis: a JACC White Paper.
        J Am Coll Cardiol. 2009; 28: 1475-1487
        • Ammirati E.
        • Moroni F.
        • Sormani P.
        • et al.
        Quantitative changes in late gadolinium enhancement at cardiac magnetic resonance in the early phase of acute myocarditis.
        Int J Cardiol. 2017; 231: 216-221
        • Luetkens J.A.
        • Homsi R.
        • Sprinkart A.M.
        • et al.
        Incremental value of quantitative CMR including parametric mapping for the diagnosis of acute myocarditis.
        Eur Heart J Cardiovasc Imaging. 2016; 17: 154-161
        • Francone M.
        • Chimenti C.
        • Galea N.
        • Scopelliti F.
        • Verardo R.
        • Galea R.
        • Carbone I.
        • Catalano C.
        • Fedele F.
        • Frustaci A.
        CMR sensitivity varies with clinical presentation and extent of cell necrosis in biopsy-proven acute myocarditis.
        JACC Cardiovasc Imaging. 2014; 7: 254-263
        • Leone O.
        • Veinot J.P.
        • Angelini A.
        • et al.
        2011 consensus statement on endomyocardial biopsy from the Association for European Cardiovascular Pathology and the Society for Cardiovascular Pathology.
        Cardiovasc Pathol. 2012; 21: 245-274
        • Kindermann I.
        • Kindermann M.
        • Kandolf R.
        • Klingel K.
        • Bultmann B.
        • Muller T.
        • Lindinger A.
        • Bohm M.
        Predictors of outcome in patients with suspected myocarditis.
        Circulation. 2008; 118: 639-648
        • Bennett M.K.
        • Gilotra N.A.
        • Harrington C.
        • Rao S.
        • Dunn J.M.
        • Freitag T.B.
        • Halushka M.K.
        • Russell S.D.
        Evaluation of the role of endomyocardial biopsy in 851 patients with unexplained heart failure from 2000–2009.
        Circ Heart Fail. 2013; 6: 676-684
        • Ogunbayo G.O.
        • Elayi S.C.
        • Ha L.D.
        • Olorunfemi O.
        • Elbadawi A.
        • Saheed D.
        • Sorrell V.L.
        Outcomes of heart block in myocarditis: a review of 31,760 patients.
        Heart Lung Circ. 2017; (S1443-9506(17)31528-7)
        • JCS Joint Working Group
        Guidelines for diagnosis and treatment of myocarditis (JCS 2009): digest version.
        Circ J. 2011; 75: 734-743
        • Anzini M.
        • Merlo M.
        • Artico J.
        • Sinagra G.
        Arrhythmic risk prediction of acute myocarditis presenting with life-threatening ventricular tachyarrhythmias.
        Int J Cardiol. 2016; 212: 169-170
        • Yang Y.W.
        • Wu C.H.
        • Ko W.J.
        • Wu V.C.
        • Chen J.S.
        • Chou N.K.
        • Lai H.S.
        Prevalence of acute kidney injury and prognostic significance in patients with acute myocarditis.
        PLoS One. 2012; 7: e48055
        • Ohara N.
        • Kaneko M.
        • Kuwano H.
        • Ebe K.
        • Fujita T.
        • Nagai T.
        • Furukawa T.
        • Aizawa Y.
        • Kamoi K.
        Fulminant type 1 diabetes mellitus and fulminant viral myocarditis. A case report and literature review.
        Int Heart J. 2015; 56: 239-244
        • Cooper Jr., L.T.
        • Menon S.
        • Deng M.
        • et al.
        Usefulness of immunosuppression for giant cell myocarditis.
        Am J Cardiol. 2008; 102: 1535-1539
        • Chung M.K.
        The role of the wearable cardioverter defibrillator in clinical practice.
        Cardiol Clin. 2014; 32: 253-270
        • Kandolin R.
        • Lehtonen J.
        • Salmenkivi K.
        • Raisanen-Solowski A.
        • Lommi J.
        • Kupari M.
        Diagnosis, treatment, and outcome of giant-cell myocarditis in the era of combined immunosuppression.
        Circ Heart Fail. 2013; 6: 15-22
        • Kron J.
        • Sauer W.
        • Schuller J.
        • et al.
        Efficacy and safety of implantable cardiac defibrillators for treatment of ventricular arrhythmias in patients with cardiac sarcoidosis.
        Europace. 2013; 15: 347-354
        • Grün S.
        • Schumm J.
        • Greulich S.
        • et al.
        Longterm follow-up of biopsy-proven viral myocarditis: predictors of mortality and incomplete recovery.
        J Am Coll Cardiol. 2012; 59: 1604-1615
        • Friedman R.A.
        • Kearney D.L.
        • Moak J.P.
        • Fenrich A.L.
        • Perry J.C.
        Persistence of ventricular arrhythmia after resolution of occult myocarditis in children and young adults.
        J Am Coll Cardiol. 1994; 24: 780-783
        • Zorzi A.
        • Perazzolo-Marra M.
        • Rigato I.
        • et al.
        Nonischemic left ventricular scar as a substrate of life-threatening ventricular arrhythmias and sudden cardiac death in competitive athletes.
        Circ Arrhythm Electrophysiol. 2016; 9: e004229
        • Patel R.A.
        • DiMarco J.P.
        • Akar J.G.
        • Voros S.
        • Kramer C.M.
        Chagas myocarditis and syncope.
        J Cardiovasc Magn Reson. 2005; 7: 685-688
        • Pinto Y.M.
        • Elliot P.M.
        • Arbustini E.
        • et al.
        Proposal for a revised definition of dilated cardiomyopathy, hypokinetic non-dilated cardiomyopathy, and its implications for clinical practice: a position statement of the ESC working group on myocardial and pericardial diseases.
        Eur Heart J. 2016; 37: 1850-1858
        • Farooq M.U.
        • Bhatt A.
        • Patel M.B.
        Neurotoxic and cardiotoxic effects of cocaine and ethanol.
        J Med Toxicol. 2009; 5: 134-138
        • Muser D.
        • Piccoli G.
        • Puppato M.
        • Proclemer A.
        • Nucifora G.
        Incremental value of cardiac magnetic resonance imaging in the diagnostic work-up of patients with apparently idiopathic ventricular arrhythmias of left ventricular origin.
        Int J Cardiol. 2015; 180: 142-144
        • Jeserich M.
        • Merkely B.
        • Olschewski M.
        • Kimmel S.
        • Pavlik G.
        • Bode C.
        Patients with exercise-associated ventricular ectopy present evidence of myocarditis.
        J Cardiovasc Magn Reson. 2015; 17: 100
        • Corrado D.
        • Basso C.
        • Leoni L.
        • et al.
        Three-dimensional electroanatomic voltage mapping increases accuracy of diagnosing arrhythmogenic right ventricular cardiomyopathy/dysplasia.
        Circulation. 2005; 111: 3042-3050
        • Dello Russo A.
        • Pieroni M.
        • Santangeli P.
        • et al.
        Concealed cardiomyopathies in competitive athletes with ventricular arrhythmias and an apparently normal heart: role of cardiac electroanatomical mapping and biopsy.
        Heart Rhythm. 2011; 8: 1915-1922
        • Maccabelli G.
        • Tsiachris D.
        • Silberbauer J.
        • et al.
        Imaging and epicardial substrate ablation of ventricular tachycardia in patients late after myocarditis.
        Europace. 2014; 16: 1363-1372
        • Thiene G.
        • Bruneval P.
        • Veinot J.
        • Leone O.
        Diagnostic use of the endomyocardial biopsy: a consensus statement.
        Virchows Arch. 2013; 463: 1-5
        • Unterberg-Buchwald C.
        • Ritter C.O.
        • Reupke V.
        • Wilke R.N.
        • Stadelmann C.
        • Steinmetz M.
        • Schuster A.
        • Hasenfuß G.
        • Lotz J.
        • Uecker M.
        Targeted endomyocardial biopsy guided by real-time cardiovascular magnetic resonance.
        J Cardiovasc Magn Reson. 2017; 19: 45
        • Casella M.
        • Pizzamiglio F.
        • Dello Russo A.
        • et al.
        Feasibility of combined unipolar and bipolar voltage maps to improve sensitivity of endomyocardial biopsy.
        Circ Arrhythm Electrophysiol. 2015; 8: 625-632
        • Mohsen A.
        • Jimenez A.
        • Hood R.E.
        • Dickfeld T.
        • Saliaris A.
        • Shorofsky S.
        • Saba M.M.
        Cardiac sarcoidosis: electrophysiological outcomes on long-term follow-up and the role of the implantable cardioverter-defibrillator.
        J Cardiovasc Electrophysiol. 2014; 25: 171-176
        • Kuhl U.
        • Pauschinger M.
        • Seeberg B.
        • Lassner D.
        • Noutsias M.
        • Poller W.
        • Schultheiss H.P.
        Viral persistence in the myocardium is associated with progressive cardiac dysfunction.
        Circulation. 2005; 112: 1965-1970
        • Murtagh G.
        • Laffin L.J.
        • Beshai J.F.
        • et al.
        Prognosis of myocardial damage in sarcoidosis patients with preserved left ventricular ejection fraction: risk stratification using cardiovascular magnetic resonance.
        Circ Cardiovasc Imaging. 2016; 9: e003738
        • Crawford T.
        • Mueller G.
        • Sarsam S.
        • et al.
        Magnetic resonance imaging for identifying patients with cardiac sarcoidosis and preserved or mildly reduced left ventricular function at risk of ventricular arrhythmias.
        Circ Arrhythm Electrophysiol. 2014; 7: 1109-1115
        • Mehta D.
        • Mori N.
        • Goldbarg S.H.
        • Lubitz S.
        • Wisnivesky J.P.
        • Teirstein A.
        Primary prevention of sudden cardiac death in silent cardiac sarcoidosis: role of programmed ventricular stimulation.
        Circ Arrhythm Electrophysiol. 2011; 4: 43-48
        • Mazzone P.
        • Tsiachris D.
        • Della Bella P.
        Epicardial management of myocarditis-related ventricular tachycardia.
        Eur Heart J. 2013; 34: 244
        • Jefic D.
        • Joel B.
        • Good E.
        • Morady F.
        • Rosman H.
        • Knight B.
        • Bogun F.
        Role of radiofrequency catheter ablation of ventricular tachycardia in cardiac sarcoidosis: report from a multicenter registry.
        Heart Rhythm. 2009; 6: 189-195